vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and BJs RESTAURANTS INC (BJRI). Click either name above to swap in a different company.
BJs RESTAURANTS INC is the larger business by last-quarter revenue ($355.4M vs $196.0M, roughly 1.8× Axsome Therapeutics, Inc.). BJs RESTAURANTS INC runs the higher net margin — 3.6% vs -14.6%, a 18.1% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 3.2%). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 2.6%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
BJ's Restaurants Inc. operates a chain of casual dining restaurants across the United States. Its menu features signature deep-dish pizzas, craft beers, handcrafted cocktails, and a wide range of American comfort food. The brand primarily serves family groups, friend gatherings, and casual diners seeking affordable, high-quality meals in a relaxed, welcoming in-store environment.
AXSM vs BJRI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $355.4M |
| Net Profit | $-28.6M | $12.6M |
| Gross Margin | — | 74.5% |
| Operating Margin | -13.8% | 3.1% |
| Net Margin | -14.6% | 3.6% |
| Revenue YoY | 65.0% | 3.2% |
| Net Profit YoY | 61.9% | -24.2% |
| EPS (diluted) | $-0.55 | $0.58 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | $355.4M | ||
| Q3 25 | $171.0M | $365.6M | ||
| Q2 25 | $150.0M | $348.0M | ||
| Q1 25 | $121.5M | — | ||
| Q4 24 | $118.8M | $325.7M | ||
| Q3 24 | $104.8M | $349.9M | ||
| Q2 24 | $87.2M | $337.3M | ||
| Q1 24 | $75.0M | — |
| Q4 25 | $-28.6M | $12.6M | ||
| Q3 25 | $-47.2M | $22.2M | ||
| Q2 25 | $-48.0M | $13.5M | ||
| Q1 25 | $-59.4M | — | ||
| Q4 24 | $-74.9M | $-2.9M | ||
| Q3 24 | $-64.6M | $17.2M | ||
| Q2 24 | $-79.3M | $7.7M | ||
| Q1 24 | $-68.4M | — |
| Q4 25 | — | 74.5% | ||
| Q3 25 | — | 75.2% | ||
| Q2 25 | — | 75.0% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 73.4% | ||
| Q3 24 | — | 74.3% | ||
| Q2 24 | — | 74.8% | ||
| Q1 24 | — | — |
| Q4 25 | -13.8% | 3.1% | ||
| Q3 25 | -27.0% | 5.8% | ||
| Q2 25 | -24.5% | 4.3% | ||
| Q1 25 | -46.9% | — | ||
| Q4 24 | -61.1% | -0.8% | ||
| Q3 24 | -59.8% | 3.8% | ||
| Q2 24 | -89.5% | 2.4% | ||
| Q1 24 | -89.7% | — |
| Q4 25 | -14.6% | 3.6% | ||
| Q3 25 | -27.6% | 6.1% | ||
| Q2 25 | -32.0% | 3.9% | ||
| Q1 25 | -48.9% | — | ||
| Q4 24 | -63.1% | -0.9% | ||
| Q3 24 | -61.7% | 4.9% | ||
| Q2 24 | -91.0% | 2.3% | ||
| Q1 24 | -91.1% | — |
| Q4 25 | $-0.55 | $0.58 | ||
| Q3 25 | $-0.94 | $0.97 | ||
| Q2 25 | $-0.97 | $0.58 | ||
| Q1 25 | $-1.22 | — | ||
| Q4 24 | $-1.54 | $-0.13 | ||
| Q3 24 | $-1.34 | $0.72 | ||
| Q2 24 | $-1.67 | $0.32 | ||
| Q1 24 | $-1.44 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $23.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $88.3M | $366.2M |
| Total Assets | $689.8M | $1.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | $23.8M | ||
| Q3 25 | $325.3M | $26.0M | ||
| Q2 25 | $303.0M | $19.0M | ||
| Q1 25 | $300.9M | — | ||
| Q4 24 | $315.4M | $18.4M | ||
| Q3 24 | $327.3M | $16.2M | ||
| Q2 24 | $315.7M | $18.8M | ||
| Q1 24 | $331.4M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $60.5M | ||
| Q2 25 | — | $85.5M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $66.5M | ||
| Q3 24 | — | $63.5M | ||
| Q2 24 | — | $58.0M | ||
| Q1 24 | — | — |
| Q4 25 | $88.3M | $366.2M | ||
| Q3 25 | $73.7M | $386.6M | ||
| Q2 25 | $73.1M | $371.5M | ||
| Q1 25 | $53.2M | — | ||
| Q4 24 | $57.0M | $376.2M | ||
| Q3 24 | $92.9M | $386.5M | ||
| Q2 24 | $102.9M | $375.4M | ||
| Q1 24 | $144.0M | — |
| Q4 25 | $689.8M | $1.0B | ||
| Q3 25 | $669.3M | $1.0B | ||
| Q2 25 | $639.8M | $1.0B | ||
| Q1 25 | $596.7M | — | ||
| Q4 24 | $568.5M | $1.0B | ||
| Q3 24 | $561.5M | $1.0B | ||
| Q2 24 | $548.2M | $1.0B | ||
| Q1 24 | $545.7M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.16× | ||
| Q2 25 | — | 0.23× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | — | 0.16× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | — |
| Free Cash FlowOCF − Capex | $-18.7M | — |
| FCF MarginFCF / Revenue | -9.6% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | — | ||
| Q3 25 | $1.0M | $62.3M | ||
| Q2 25 | $-32.4M | $4.6M | ||
| Q1 25 | $-43.4M | — | ||
| Q4 24 | $-26.2M | $27.3M | ||
| Q3 24 | $-18.6M | $20.2M | ||
| Q2 24 | $-30.1M | $22.3M | ||
| Q1 24 | $-53.5M | — |
| Q4 25 | $-18.7M | — | ||
| Q3 25 | $988.0K | $41.9M | ||
| Q2 25 | $-32.4M | $-12.1M | ||
| Q1 25 | $-43.7M | — | ||
| Q4 24 | $-26.2M | $7.6M | ||
| Q3 24 | $-18.7M | $735.0K | ||
| Q2 24 | $-30.2M | $448.0K | ||
| Q1 24 | $-53.6M | — |
| Q4 25 | -9.6% | — | ||
| Q3 25 | 0.6% | 11.5% | ||
| Q2 25 | -21.6% | -3.5% | ||
| Q1 25 | -36.0% | — | ||
| Q4 24 | -22.1% | 2.3% | ||
| Q3 24 | -17.9% | 0.2% | ||
| Q2 24 | -34.6% | 0.1% | ||
| Q1 24 | -71.4% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | 5.6% | ||
| Q2 25 | 0.0% | 4.8% | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 0.0% | 6.0% | ||
| Q3 24 | 0.1% | 5.6% | ||
| Q2 24 | 0.1% | 6.5% | ||
| Q1 24 | 0.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 2.80× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.18× | ||
| Q2 24 | — | 2.89× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
